INBS Intelligent Bio Solutions Inc.

NASDAQ
$2.51

Intelligent Bio Solutions Inc. (INBS) Institutional Ownership

What the institutions did with INBS last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
10
filed a 13F this quarter
Managers holding
8
-1 on the quarter
Buyers
4
1 opened new
Sellers
3
2 sold out entirely
Buyer share
57.1%
of managers who traded it
Breadth
+14.3
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
ARMISTICE CAPITAL, LLC 141.4K 78.0%
GEODE CAPITAL MANAGEMENT, LLC 20.8K 11.5%
VANGUARD CAPITAL MANAGEMENT LLC 5.8K 3.2%
UBS Group AG 5.7K 3.2%
VANGUARD FIDUCIARY TRUST CO 4.0K 2.2%
Tower Research Capital LLC (TRC) 3.3K 1.8%
OSAIC HOLDINGS, INC. 200 0.1%
BARCLAYS PLC 142 0.1%

Largest changes

Manager Action Previous Current Change
Alyeska Investment Group, L.P. Sold Out 38.0K 0 -38.0K
ARMISTICE CAPITAL, LLC Increased 130.0K 141.4K +11.4K
GEODE CAPITAL MANAGEMENT, LLC Reduced 28.6K 20.8K -7.8K
UBS Group AG Increased 372 5.7K +5.4K
Tower Research Capital LLC (TRC) Increased 1.3K 3.3K +2.0K
CURIO WEALTH, LLC Sold Out 200 0 -200
BARCLAYS PLC New 0 142 +142

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.